Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Chinese Academy of Medical Sciences | OTHER |
| First Affiliated Hospital of Zhejiang University | OTHER |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | OTHER |
Not provided
Not provided
Not provided
Not provided
This is a prospective, multicenter observational study for recipients of hematopoietic stem cell transplantation. Patients who underwent hematopoietic stem cell transplantation at the participating centers will be entrolled in the study. The clinical characteristics, laboratory profiles, management measures, and clinical outcomes such as post-transplant cardiovascular events will be prospectively collected.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patients undergoing hematopoietic stem cell transplantation | Patients who undergo allogeneic hematopoietic stem cell transplantation at participating medical center. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Major adverse cardiovascular events (MACE) | Major adverse cardiovascular events (MACE) after hematopoietic stem cell transplantation. | At 30 days, 100 days, 3 months, 6 months, 1 years, 3 years, 5 years post hematopoietic stem cell transplantation. |
| Measure | Description | Time Frame |
|---|---|---|
| Cardiovascular events | Cardiovascular events after hematopoietic stem cell transplantation, such as cardiovascular death, ischemic heart disease, coronary artery disease, stroke, heart failure, arrhythmia cardiomyopathy, myocarditis, endocarditis, valvular heart disease, and pericardial disease. | At 30 days, 100 days, 3 months, 6 months, 1 years, 3 years, 5 years post hematopoietic stem cell transplantation. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients who undergo hematopoietic cell transplantation at any of the participating medical centers.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Xiao Hui Zhang | Contact | 861088324577 | zhangxh@bjmu.edu.cn |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Chinese PLA General Hospital | Recruiting | Beijing | Beijing Municipality | China |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Tongji Hospital | OTHER |
| Xinqiao hospital of the third military medical university | UNKNOWN |
| The First Affiliated Hospital of Zhengzhou University | OTHER |
| Sun Yat-Sen University Cancer Center | OTHER |
| Sichuan Provincial People's Hospital | OTHER |
| First Affiliated Hospital of Harbin Medical University | OTHER |
| First Affiliated Hospital Xi'an Jiaotong University | OTHER |
| First Affiliated Hospital of Xinjiang Medical University | OTHER |
| Chinese PLA General Hospital | OTHER |
| Peking University Shenzhen Hospital | OTHER |
| Peking University Third Hospital | OTHER |
| Peking University First Hospital | OTHER |
Not provided
Not provided
Not provided
| Overall survival | Overall survival after hematopoietic stem cell transplantation. | At 30 days, 100 days, 3 months, 6 months, 1 years, 3 years, 5 years post hematopoietic stem cell transplantation. |
| Event-free survival | Events were defined as the occurrence of any of the following after allo-HSCT: grade III-IV acute graft-versus-host disease (GVHD), chronic GVHD requiring systemic immunosuppression, relapse or progression of the hematologic disease, or death from any cause during follow-up. | At 30 days, 100 days, 3 months, 6 months, 1 years, 3 years, 5 years post hematopoietic stem cell transplantation. |
| Complications of hematopoietic stem cell transplantation | Complications arising from hematopoietic stem cell transplantation range from early issues such as regimen toxicity and acute GVHD to late effects including chronic GVHD, organ dysfunction, and secondary malignancies. | At 30 days, 100 days, 3 months, 6 months, 1 years, 3 years, 5 years post hematopoietic stem cell transplantation. |
| Peking University First Hospital | Recruiting | Beijing | Beijing Municipality | China |
|
| Peking University People's Hospital | Recruiting | Beijing | Beijing Municipality | China |
|
| Peking University Third Hospital | Recruiting | Beijing | Beijing Municipality | China |
|
| Xinqiao hospital of the third military medical university | Recruiting | Chongqing | Chongqing Municipality | China |
|
| Sun Yat-sen University Cancer Center, Sun Yat-sen University | Recruiting | Guangzhou | Guangdong | China |
|
| Peking University Shenzhen Hospital | Recruiting | Shenzhen | Guangdong | China |
|
| First Affiliated Hospital of Harbin Medical University | Recruiting | Harbin | Heilongjiang | China |
|
| The First Affiliated Hospital of Zhengzhou University | Recruiting | Zhengzhou | Henan | China |
|
| Tongji Hospital, Affiliated to Tongji Medical College of Huazhong University of Science and Technology | Recruiting | Wuhan | Hubei | China |
|
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Recruiting | Wuhan | Hubei | China |
|
| First Affiliated Hospital Xi'an Jiaotong University | Recruiting | Xi'an | Shaanxi | China |
|
| Sichuan Provincial People's Hospital | Recruiting | Chengdu | Sichuan | China |
|
| Hematology Hospital of Chinese Academy of Medical Sciences (Hematology Research Center of Chinese Academy of Medical Sciences) | Recruiting | Tianjin | Tianjin Municipality | China |
|
| First Affiliated Hospital of Xinjiang Medical University | Recruiting | Ürümqi | Xinjiang | China |
|
| First Affiliated Hospital of Zhejiang University | Recruiting | Hangzhou | Zhejiang | China |
|